“If I think about the psychedelic future I want to see, what should be the first point of contact for someone? I think it’s community” — Mike Margolies, co-founder of the Global Psychedelic Society.
The psychedelic landscape is undergoing a seismic shift. After decades of prohibition and stigma, substances such as psilocybin and MDMA are being recognised for their profound therapeutic potential. Historic legal changes in Oregon, Colorado and Australia are creating new regulated paths to healing. But as psychedelics move from the underground to mainstream acceptance, the community faces a critical, defining tension: how can the rigour of Western science and regulation coexist with the sacred, community-centred wisdom of the Indigenous traditions that have cared for these medicines for generations?
A recurring virtual gathering aims to explore exactly these questions (edition of Saturday 28 February 2026). “The Evolving Psychedelic Ecosystem”, organised by the Synthesis Institute, brings together architects of the movement — including Rick Doblin and Dr Rosalind Watts — for a day of live conversation on the past, present and future of psychedelic medicine.
Science meets tradition
The modern “psychedelic renaissance” is driven largely by compelling clinical research. Institutions such as Johns Hopkins and Imperial College London have published studies showing psilocybin’s great potential for treating severe depression, PTSD and addiction. This science has driven regulatory milestones, such as the FDA’s “breakthrough therapy” designation and the approval of psilocybin in Australia for treatment-resistant depression.
However, this biomedical model focuses on treating individual brains and symptoms. It often contrasts sharply with Indigenous frameworks, where plant medicines are not “treatments” for “disorders” but sacred tools for restoring harmony between the individual, their community and the natural world. A Shipibo onaya (healer) from the Peruvian Amazon, for example, explains that true health comes from knowing “how to live in harmony and reciprocity with other people and with our environment as a whole”.
There is growing concern that, in the race towards medicalisation, this essential holistic wisdom is being sidelined or commodified. As critics point out, sacred plants used for centuries risk being “decontextualised and reduced to symptom relief and individual achievement”.
Global shifts in psychedelic policy and practice
| Aspect | Western medical/regulatory model | Indigenous and community framework |
|---|---|---|
| Main goal | Treat diagnosed mental health conditions | Restore holistic balance and interconnection |
| Context | Clinical settings, licensed service centres | Ceremonial, community and ecological context |
| Authority of knowledge | Clinical trials, academic research, regulatory bodies | Lineage, ancestral wisdom, direct relationship with the medicine |
| Legal approach | Legalisation for regulated therapeutic access | Decriminalisation to protect traditional and community use |
| Risks | High cost, exclusivity, loss of cultural context | Lack of safety standards, vulnerability to exploitation |
Navigating the legal maze
The legal terrain is a patchwork, reflecting these competing philosophies. In the United States there is no federal legalisation, but some states are breaking ground with different approaches.
- Oregon has created a licensed, non-medical facilitation model, separating psilocybin services from the health system.
- Colorado’s Natural Medicine Health Act goes further, decriminalising personal use while building a regulated therapeutic framework that allows integration with psychotherapy.
- New Mexico is developing its own programme, due to launch in late 2026.
This state-by-state progression underlines a central debate: legalisation versus decriminalisation. Legalisation creates regulated markets, which can guarantee safety and build widespread trust, but can also create costly bureaucratic hurdles. Decriminalisation removes criminal penalties for personal use, protecting traditional and community practices, but offers fewer public health controls.
Advocates such as Mike Margolies warn of a potential two-tier model: “If you create a regulated legal model,” he says, “without also decriminalising, you can end up in a scenario where there is regulated access, but people who run community healing ceremonies could still be criminalised”. The ideal, many argue, is a hybrid model that allows both safe, regulated clinical access and the protection of sacred community-based practices.
Community, ethics and reciprocity
So how does the field move forward without fracturing? The answer may lie in intentional community-building and ethical scaffolding. Grassroots “psychedelic societies” around the world are acting as a vital “third pillar” of change, complementing top-down political and medical efforts with cultural education and bottom-up support. These communities provide essential spaces for integration, harm reduction and preserving the movement’s ethos .
At the same time, training programmes for the next generation of facilitators are emphasising ethical foundations. The Synthesis Institute’s core training, for example, uses a “four lenses” approach, educating practitioners through the lenses of embodied, cognitive, sacred and relational wisdom. This model explicitly seeks to bridge scientific knowledge and tradition, preparing facilitators to honour “many ways of knowing”. It includes a deep exploration of “cultural appropriation, extractivism, restorative justice and generative reciprocity”, themes central to the current tension.
Join the conversation
The journey from taboo to transformation is at a delicate stage. The decisions made now will determine whether psychedelics become yet another commodified tool within a hyper-individualistic wellness industry or catalyse a broader healing of our relationships with ourselves, others and the planet.
The gathering “The Evolving Psychedelic Ecosystem” is designed to deepen these urgent questions. In the 2026 edition, three consecutive live conversations explored:
- The defining tensions between lineage and scalability, and between medicalisation and community care.
- The many roles within the ecosystem and how different traditions inform practice.
- The perspective of leaders who have navigated both advances and setbacks.
The event is free and everyone who registers receives permanent access to the recordings. The Synthesis Institute, which has guided more than 1,100 legal psychedelic experiences, notes that this work takes more than credentials — it demands “deep personal exploration” and a commitment to inner transformation in order to serve others ethically. This dialogue is a step in that collective exploration.
Watch the free recording:
The Evolving Psychedelic Ecosystem
Saturday 28 February 2026
Interested in taking this path further professionally? The ethical integration of scientific and traditional knowledge is the basis of our collaboration with the Synthesis Institute. As affiliates, we can offer you exclusive access to their Workshop Series on Psychedelic Practitioner Fundamentals, a free training that is an ideal first step for those who want to contribute to the future of this field with rigour and respect for its roots.



